Diabetes: Management and Pharmacotherapy

Diabetes therapy aims to achieve glycemic control, alleviate hyperglycemia-related symptoms, and prevent or reduce chronic end-organ complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease. Comprehensive care also addresses abnormalities in blood pressure and lipids to reduce overall metabolic risk.

Glycemic control is evaluated using both short-term and long-term metrics. Short-term assessment includes self-monitoring of blood glucose and continuous glucose monitoring for near real-time tracking. Long-term assessment uses A1c tests and fructosamine measurement, which reflect glycemic control over specific time frames and enable comprehensive monitoring.

Subcutaneous insulin administration is the cornerstone of treatment for all patients with type 1 diabetes and many with type 2 diabetes because it leads to near-normal glycemia. Although it differs from physiological insulin secretion in absorption kinetics and circulation dynamics, it remains the most effective long-term therapy for achieving optimal glucose control.

In type 1 diabetes, the dietary focus is on matching caloric intake with insulin dosing to maintain glycemic balance. In type 2 diabetes, the dietary approach emphasizes weight loss, blood pressure reduction, and lowering atherosclerotic risk to improve metabolic outcomes and reduce cardiovascular complications.

Nonpharmacologic diabetes therapy includes patient education about nutrition and exercise to lower plasma glucose levels. These lifestyle modifications are essential components of comprehensive care and work alongside pharmacologic treatments to improve glycemic control and reduce the risk of diabetes-related complications.

Treatment goals are individualized based on patient-specific factors including age, life expectancy, risk of hypoglycemia, presence of advanced complications, and other medical conditions. Patient attitudes, expectations, available resources, support systems, and cost considerations also influence treatment planning to ensure realistic and sustainable outcomes.

Metabolic surgery has shown promising results in preventing or reversing type 2 diabetes, surpassing medical management efficacy in clinical trials. This surgical approach represents an alternative intervention for select patients when conventional pharmacologic and lifestyle therapies have not achieved adequate glycemic control.